The BASE facility provides the ideal environment for high quality research, between industry and academia, which contributes to advancing the science of nutrition, sleep and physical activity. The facility comprises of a sleep laboratory, a commercial kitchen, exercise and fitness studio and consulting suites. The team can help food businesses with feasibility studies; proof of concept; proof of efficacy; identify health claims; design and conduct human intervention trials following Good Clinical Practice guidelines.
The Monash Bioinformatics Platform exists to create a hub for bioinformatics activities at Monash. We have a core group of bioinformaticians with broad expertise and are building a loosely linked community of bioinformaticians across all of Monash. We are always available to help with specialist advice on experimental design or analysis. We also collaborate with groups around Monash on specific research projects. We also teach scientists bioinformatics analysis skills through our hands on training workshops.
+61 (3) 9902 9186
The Centre for Drug Candidate Optimisation (CDCO) is a collaborative research centre based within the Monash Institute of Pharmaceutical Sciences that undertakes drug candidate optimisation to accelerate and enhance drug discovery and development for commercial, not-for-profit and academic research organisations. Drug candidate optimisation is a critical value-creating step in drug discovery/development which enhances the future developmental and commercial potential of candidate drugs through optimisation of their metabolic, physicochemical, pharmacokinetic and bioavailability properties.
The Monash Ramaciotti Centre is a leading facility for life sciences electron microscopy. It houses Australia’s first Titan Krios microscope, currently the most advanced microscope for biological EM. The facility’s expert team supports and collaborates on a large number of bio EM techniques ranging from standard SEM and TEM to immuno EM, correlative light and electron microscopy, cryo tomography and single particle analysis.
Macromolecular crystallography provides unparalleled details of the 3D structures of biological macromolecules and provides the basis for the rational design of therapeutics. The Monash Macromolecular Crystallisation Facility delivers access to a fully automated platform for the high-throughput crystallisation of biological macromolecules. The use of robotics allows for miniaturisation of crystallisation experiments, which enables screening of a wide range of conditions with/from limited sample volumes.
+61 (3) 9905 9788
eResearch is 21st century research discovery through the application of advanced computing and IT. The Monash eResearch Centre partners with research groups to accelerate and transform knowledge, connecting them to the most appropriate hardware, software and services to sustain that capability. It leads a number of national and international eResearch initiatives and has links with: AuScope, MASSIVE and the Monash Bioinformatics and Immersive Visualisation platforms.
+61 (3) 9902 0711
The ARMI AquaCore facility is the largest zebrafish facility of its kind in the southern hemisphere, consisting of 1000 quarantine tanks and 5200 main facility tanks (non quarantine). It houses genetically modified and mutant strains of zebrafish to model a variety of human diseases and conditions. Additional services include a sperm freezing and rederivation service for any long term storage requirements. AquaCore is also currently running a pilot system to house axolotl and shark embryos for research, with the intention of developing larger scale facilities in the future.
+61 (3) 990 29613
FlowCore provides flow cytometry services to researchers within Monash University and the wider scientific community. Flow cytometry is a high speed laser based technology enabling users to generate multiparametric data about the size and shape of the proteins associated with cells or particles of interest. Flow cytometry is a powerful tool in many fields including immunology, stem cell science, cancer research, aquatic biology and plant biology.
+61 (3) 9902 0271
Monash Food Innovation is an industry shared world class facility operated by experts who will work with you to discover your opportunities, create the design criteria aided by consumers to answer the innovation need, confirm with a range of rapid testing and prototyping the key deliverables of our offer and support you with partners to develop and launch your innovation.
The Monash Fragment Platform (MFP) provides academic and commercial researchers with access to fragment-based drug discovery (FBDD) technologies for their therapeutic targets. The facilities are located at the Monash Institute for Pharmaceutical Sciences (MIPS) in Parkville, Australia’s largest and most successful pharmaceutical institute. FBDD screening uses our high-quality, in-house fragment library designed to maximise chemical space coverage and enable rapid hit optimisation. Screening cascades are tailored for each target and can be performed using a variety of techniques including NMR spectroscopy and our state-of-the-art surface plasmon resonance (SPR) facility. Structural biology and medicinal chemistry expertise utilising our standardized REFIL strategy enables the rapid elaboration of fragments into leads without the requirement for a large chemistry program.